Addition of Raltegravir to Established Antiretroviral Suppressive Therapy
This study is ongoing, but not recruiting participants.
University of Miami
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Rafael Campo, University of Miami
First received: November 19, 2010
Last updated: June 1, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||October 2015|
|Primary Completion Date:||October 2012 (Final data collection date for primary outcome measure)|